RSG
67
2
BEN
41
-9
DG
36
-2
OXY
46
2
TXT
75
6
BIIB
45
-3
BWA
61
-7
EL
55
-3
FOX
50
2
CHD
62
-2
GIS
58
-2
SYF
83
2
COP
47
2
APA
30
5
EA
47
-3
MAC
71
-4
URBN
60
-3
JPM
71
2
ZBH
48
-2
PSA
48
2
RSG
67
2
BEN
41
-9
DG
36
-2
OXY
46
2
TXT
75
6
BIIB
45
-3
BWA
61
-7
EL
55
-3
FOX
50
2
CHD
62
-2
GIS
58
-2
SYF
83
2
COP
47
2
APA
30
5
EA
47
-3
MAC
71
-4
URBN
60
-3
JPM
71
2
ZBH
48
-2
PSA
48
2
Financhill
Back

Foghorn Therapeutics Vs. Viridian Therapeutics Industry Stock Comparison

Sell
45

FHTX
Foghorn Therapeutics

Last Price:
5.53
Seasonality Move:
42.54%
Sell
27

VRDN
Viridian Therapeutics

Last Price:
13.46
Seasonality Move:
-9.44%
Sell
45
Foghorn Therapeutics (FHTX) is a Sell

Is Foghorn Therapeutics a Buy, Sell or Hold?

  • The current Foghorn Therapeutics [FHTX] share price is $5.51. The Score for FHTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • FHTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Viridian Therapeutics (VRDN) is a Sell

Is Viridian Therapeutics a Buy, Sell or Hold?

  • The current Viridian Therapeutics [VRDN] share price is $13.45. The Score for VRDN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • VRDN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FHTX Stock Price Chart

What is Foghorn Therapeutics's stock price today?

  • The Foghorn Therapeutics share price today is $5.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FHTX is experiencing selling pressure, which indicates risk of future bearish movement.

VRDN Stock Price Chart

What is Viridian Therapeutics's stock price today?

  • The Viridian Therapeutics share price today is $13.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRDN is experiencing selling pressure, which indicates risk of future bearish movement.

FHTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 45.19 Sell
Chaikin Money Flow: -51838 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.33 - 5.97) Sell
Bollinger Bands (100): (4.54 - 7.04) Sell

VRDN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 39.46 Sell
Chaikin Money Flow: -1009581 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.5 - 15.16) Sell
Bollinger Bands (100): (15.22 - 20.68) Sell

FHTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.67 Sell
20-day SMA: 5.61 Sell
50-day SMA: 6.18 Sell
200-day SMA: 5.67 Sell
8-day EMA: 5.64 Sell
20-day EMA: 5.76 Sell
50-day EMA: 5.93 Sell
200-day EMA: 6 Sell

VRDN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.26 Sell
20-day SMA: 14.13 Sell
50-day SMA: 15.82 Sell
200-day SMA: 17.2 Sell
8-day EMA: 14.23 Sell
20-day EMA: 14.51 Sell
50-day EMA: 15.61 Sell
200-day EMA: 18.02 Sell

Foghorn Therapeutics Earnings Growth & FHTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.71 per share.

Viridian Therapeutics Earnings Growth & VRDN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.07 per share, an increase this year of $1.15 per share, and a decrease next year of $0.05 per share.

Foghorn Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viridian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):